InvestorsHub Logo
Followers 23
Posts 1331
Boards Moderated 1
Alias Born 09/25/2018

Re: A deleted message

Monday, 08/12/2019 8:36:10 PM

Monday, August 12, 2019 8:36:10 PM

Post# of 701551
From the risks section of the 10-K

Changes in manufacturing methods for DCVax-L could require us to conduct equivalency studies and/or additional clinical trials.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News